<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04948736</url>
  </required_header>
  <id_info>
    <org_study_id>B-2010/645-005</org_study_id>
    <nct_id>NCT04948736</nct_id>
  </id_info>
  <brief_title>Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia</brief_title>
  <acronym>MENTORS</acronym>
  <official_title>Effectiveness and Clinical Application of Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenic Older Adults With Metabolic Sybdrome: Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Evidence-Based Healthcare Collaborating Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to demonstrate the effect of combined exercise-nutrition intervention in old&#xD;
      adults with sarcopenia. This study will be conducted with prospectively randomized controlled&#xD;
      trial comparing outcome of combined exercise-nutrition intervention with conventional medical&#xD;
      care. Handgrip strength, gait speed, knee extensor muscle power, physical performance, muscle&#xD;
      mass using DEXA, quality of life, activities of daily living, sarcopenia screening&#xD;
      questionnaire, nutritional assessment will be evaluated on baseline, 12-weeks and 24-weeks&#xD;
      after intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The definition of sarcopenia is age-related loss of skeletal muscle and physical functions.&#xD;
      Sarcopenia is emerging health problem and increases medical expenditure as the population&#xD;
      ages. Sarcopenia is closely related to chronic diseases and geriatric diseases. In&#xD;
      particular, patients with metabolic syndrome showed a high prevalence of muscle loss and&#xD;
      muscle weakness. It has been reported exercise in sarcopenia patients not only improved&#xD;
      insulin sensitivity and physical performance but also helped the treatment of the diseases.&#xD;
      Also, it is recently demonstrated that combined exercise-nutrition intervention improved&#xD;
      muscle function in elderly patients. However, there is still not established standard&#xD;
      protocol for the combined exercise-nutrition intervention. Therefore, the aim of this trial&#xD;
      is to compare the effects of combined exercise-nutrition intervention in sarcopenia patients&#xD;
      with multicenter, multidisciplinary, randomized controlled trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Handgrip strength</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Change from baseline handgrip strength to every 12 weeks after assessment, measured in kilograms (kg) using hand-held dynamometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-times chair stand test</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Change from baseline 5-times chair stand test to every 12 weeks after assessment, measured by 5-times chair stand test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>physical performance</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Short physical performance battery [range from 0 to 12 score]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait speed test</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>measured by 4 meter gait speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee extensor muscle test</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>measured by manual muscle test and lafeyette manual muscle testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>appendicular skeletal muscle mass</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>measured using Dual-energy X-ray absorptiometry (DEXA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Evaluation of quality of life using EQ-5D [range from 5 to 25 score]. Higher value means worse quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Instrumental activities of daily living</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Evaluation of instrumental activities of daily living using Korean Instrumental Activity of Daily Living (K-IADL) [range from 0 to 33]. Low value means poor ability of activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sarcopenia screening questionnaire</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Evaluation of quality of life using Strength, Assistance with walking, Rising from a chair, Climbing stairs and Falls (SARC-F) questionnair [range from 0 to 10].</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini Nutritional Assessment</measure>
    <time_frame>Baseline (visit 2), 12 weeks after intervention (visit 3), 24 weeks after intervention (visit 4)</time_frame>
    <description>Evaluation of nutritional state using Mini-Nutritional Assessment (MNA) [range from 1 to 30 score]. decreasingly worse</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Combined exercise nutrition intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Customized exercise and nutrition intervention by underlying disease and functional state for 12 weeks during intervention period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional medial care group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional medical care service for 12weeks during intervention period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Combined exercise and nutrition intervention</intervention_name>
    <description>Combined exercise and nutrition intervention for 12 weeks. Exercise intervention includes flexibility exercise, strength exercise, aerobic exercise and balance exercise according to protocol.&#xD;
Nutritional intervention includes investigating dietary habits and calculate insufficient protein intake to provide customized diet and high protein drink</description>
    <arm_group_label>Combined exercise nutrition intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional medial care</intervention_name>
    <description>Conventional medical care service for 12weeks during intervention period. Usual care includes medical check-up and exercise and dietary counseling. During intervention period, patients maintain the usual activity and dietary habits</description>
    <arm_group_label>Conventional medial care group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients older than 65 years&#xD;
&#xD;
          -  patients who meet criteria for the Asian Working Group for Sarcopenia (AWGS) 2019&#xD;
&#xD;
          -  patients who had metabolic syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with less than estimated glomerular filtration rate (eGFR) 30&#xD;
&#xD;
          -  patients with musculoskeletal or chronic lung disease incapable of exercise&#xD;
&#xD;
          -  patients with untreated or uncontrolled cardiovascular disease which may affect muscle&#xD;
             mass or performing exercise&#xD;
&#xD;
          -  patients less than 5 years after treatment of malignant tumor&#xD;
&#xD;
          -  patients with liver cirrhosis, diabetes and other chronic disease&#xD;
&#xD;
          -  patients who cannot perform combined exercise nutrition intervention for other reasons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae-Young Lim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae-Young Lim, MD, PhD.</last_name>
    <phone>+821053900373</phone>
    <email>drlim1@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bo-Ram Kim, RN</last_name>
    <phone>+82317877732</phone>
    <email>bboram2@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Jae-Young Lim, Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, Pahor M, Clark BC, Cesari M, Ruiz J, Sieber CC, Aubertin-Leheudre M, Waters DL, Visvanathan R, Landi F, Villareal DT, Fielding R, Won CW, Theou O, Martin FC, Dong B, Woo J, Flicker L, Ferrucci L, Merchant RA, Cao L, Cederholm T, Ribeiro SML, Rodríguez-Mañas L, Anker SD, Lundy J, Gutiérrez Robledo LM, Bautmans I, Aprahamian I, Schols JMGA, Izquierdo M, Vellas B. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9.</citation>
    <PMID>30498820</PMID>
  </reference>
  <reference>
    <citation>Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601.</citation>
    <PMID>30312372</PMID>
  </reference>
  <reference>
    <citation>Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.</citation>
    <PMID>32033882</PMID>
  </reference>
  <reference>
    <citation>Jang HC. How to Diagnose Sarcopenia in Korean Older Adults? Ann Geriatr Med Res. 2018 Jun;22(2):73-79. doi: 10.4235/agmr.2018.22.2.73. Epub 2018 Jun 30.</citation>
    <PMID>32743250</PMID>
  </reference>
  <reference>
    <citation>Malafarina V, Uriz-Otano F, Malafarina C, Martinez JA, Zulet MA. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas. 2017 Jul;101:42-50. doi: 10.1016/j.maturitas.2017.04.010. Epub 2017 Apr 22.</citation>
    <PMID>28539168</PMID>
  </reference>
  <reference>
    <citation>Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, Gallagher ER, Jackson VA, Kambadakone A, Hong TS, Temel JS, Fintelmann FJ. Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist. 2018 Jan;23(1):97-104. doi: 10.1634/theoncologist.2017-0255. Epub 2017 Sep 21.</citation>
    <PMID>28935775</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Jae-Young Lim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Older adults</keyword>
  <keyword>Exercise</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Standard intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

